BASED ON PUBLICLY-REPORTED 2024 DIAGNOSTICS-RELATED REVENUE, four in vitro diagnostics (IVD) companies continue to dominate the global market, as they have for the last two years: Thermo Fisher Scientific, Roche, Danaher, and Abbott Laboratories. The top 13 companies reported $91.9 billion in diagnostic-related revenue in 2024 compared to $88.7 billion the year before. Danaher and […]
To access this post, you must purchase The Dark Report.